Loading insider details...
Beta
Latest Form 4 (May 18, 2026): Grant/Award of 8,741 COLL shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 18, 2026 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/Award | 8,741 | n/a |
| Dec 9, 2025 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Sale | 3,650 | $171.7K |
| May 19, 2025 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/Award | 9,791 | n/a |
| May 16, 2024 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/Award | 7,693 | n/a |
| May 19, 2023 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/Award | 9,792 | n/a |
| May 23, 2022 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/Award | 14,035 | n/a |
| May 24, 2021 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/Award | 9,941 | n/a |
| Sep 28, 2020 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/Award | 5,027 | n/a |